Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Extension/Re-treatment in Multiple Myeloma
NCT00216697Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2005
- Modality
- Small Molecules, Modified Peptides
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Janssen Pharmaceutical. Started Mar 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00216697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216697.